Aquestive Therapeutics (AQST) Q1 2025 Earnings Call May 13, 2025 08:00 AM ET Company Participants Brian Korb - Co-Founder & Managing DirectorDaniel Barber - CEO, President & DirectorErnie Toth - Chief Financial OfficerSherry Korczynski - Senior Vice President of Sales & MarketingCarl Kraus - Chief Medical OfficerJason Butler - Managing Director & Biotechnology Equity ResearchRaghuram Selvaraju - Managing Director, Healthcare Equity ResearchDenis Reznik - Senior Equity Research AssociateNelson Cox - Equity R ...

Aquestive Therapeutics (AQST) Q1 2025 Earnings Call May 13, 2025 08:00 AM ET Speaker0 Good day, and thank you for standing by. Welcome to the Aquestive Therapeutics first quarter twenty twenty five earnings conference call. At this time, all participants are in a listen only mode. After the speakers' presentation, there'll be a question and answer session. Please be advised today's conference is being recorded. I would now like to turn the conference over to your host today, Brian Korb. Please go ahead. Spe ...

First Quarter 2025 Earnings Supplemental Materials September 2024 May 12, 2025 Advancing medicines. Solving problems. Improving lives. Advancing medicines. Solving problems. Improving lives. Advancing medicines. Solving problems. Improving lives. Advancing medicines. Solving problems. Improving lives. ® Disclaimer Certain statements in this press release include "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "believe," "anticipate," "pl ...

Submitted NDA for Anaphylm™ (epinephrine), the first and only oral sublingual film for patients with severe allergic reactions Advancing commercial readiness efforts with a planned Q1 2026 launch of Anaphylm, subject to FDA approvalCompany to host investor call on May 13, 2025, at 8:00am ET WARREN, N.J., May 12, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives t ...